Antitsa Stoycheva

1.0k total citations
16 papers, 274 citations indexed

About

Antitsa Stoycheva is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Antitsa Stoycheva has authored 16 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Epidemiology. Recurrent topics in Antitsa Stoycheva's work include HIV/AIDS drug development and treatment (4 papers), interferon and immune responses (3 papers) and Hepatitis C virus research (3 papers). Antitsa Stoycheva is often cited by papers focused on HIV/AIDS drug development and treatment (4 papers), interferon and immune responses (3 papers) and Hepatitis C virus research (3 papers). Antitsa Stoycheva collaborates with scholars based in United States, Belgium and China. Antitsa Stoycheva's co-authors include Sherwin J. Singer, José N. Onuchic, Charles L. Brooks, Julian Symons, Sarah Stevens, Andreas Jekle, Keyu Wang, Choung U. Kim, Geneviève Laflamme and Tomáš Cihlář and has published in prestigious journals such as Physical Review Letters, The Journal of Chemical Physics and PLoS ONE.

In The Last Decade

Antitsa Stoycheva

16 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antitsa Stoycheva United States 10 106 73 73 64 55 16 274
Leonardo Martinelli Brazil 11 116 1.1× 134 1.8× 44 0.6× 21 0.3× 34 0.6× 24 349
Toru Kikuchi Japan 11 127 1.2× 14 0.2× 21 0.3× 44 0.7× 16 0.3× 32 379
Toru Ekimoto Japan 13 264 2.5× 10 0.1× 94 1.3× 32 0.5× 17 0.3× 39 487
Christian Haase Germany 10 158 1.5× 21 0.3× 56 0.8× 46 0.7× 21 0.4× 35 569
Alexander A. Malär Switzerland 12 74 0.7× 8 0.1× 128 1.8× 30 0.5× 31 0.6× 23 354
Marcus Wurlitzer Germany 12 151 1.4× 110 1.5× 32 0.4× 66 1.0× 21 0.4× 36 426
Y. Sato Japan 9 34 0.3× 45 0.6× 27 0.4× 41 0.6× 17 0.3× 32 264
Jingqian Liu China 10 252 2.4× 174 2.4× 64 0.9× 30 0.5× 13 0.2× 18 605
Lisa Buchauer Israel 7 133 1.3× 17 0.2× 42 0.6× 52 0.8× 32 0.6× 9 364
Michael McGovern United States 9 145 1.4× 18 0.2× 52 0.7× 67 1.0× 8 0.1× 15 271

Countries citing papers authored by Antitsa Stoycheva

Since Specialization
Citations

This map shows the geographic impact of Antitsa Stoycheva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antitsa Stoycheva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antitsa Stoycheva more than expected).

Fields of papers citing papers by Antitsa Stoycheva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antitsa Stoycheva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antitsa Stoycheva. The network helps show where Antitsa Stoycheva may publish in the future.

Co-authorship network of co-authors of Antitsa Stoycheva

This figure shows the co-authorship network connecting the top 25 collaborators of Antitsa Stoycheva. A scholar is included among the top collaborators of Antitsa Stoycheva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antitsa Stoycheva. Antitsa Stoycheva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jekle, Andreas, Suping Ren, April Kinkade, et al.. (2023). Tumor Regression upon Intratumoral and Subcutaneous Dosing of the STING Agonist ALG-031048 in Mouse Efficacy Models. International Journal of Molecular Sciences. 24(22). 16274–16274. 5 indexed citations
2.
Wu, Tongfei, Sarah Stevens, Cheng Liu, et al.. (2022). Discovery of oral PDL1 small molecule inhibitors specifically designed for the treatment of chronic hepatitis B. Journal of Hepatology. 77. S853–S853. 2 indexed citations
3.
Luong, Xuan G., Sarah Stevens, Andreas Jekle, et al.. (2020). Regulation of gene transcription by thyroid hormone receptor β agonists in clinical development for the treatment of non-alcoholic steatohepatitis (NASH). PLoS ONE. 15(12). e0240338–e0240338. 31 indexed citations
4.
Jekle, Andreas, Sarah Stevens, Caroline Williams, et al.. (2020). Abstract 4520: Preclinical characterization of ALG-031048, a novel STING agonist with potent anti-tumor activity in mice. Cancer Research. 80(16_Supplement). 4520–4520. 6 indexed citations
5.
Gonzalvez, François, Koen Vandyck, Yannick Debing, et al.. (2020). Abstract 1758: Discovery of novel potent and selective inhibitors of PRMT5 with anti-tumor activity in hepatocellular carcinoma and lung pre-clinical models. Cancer Research. 80(16_Supplement). 1758–1758. 1 indexed citations
6.
Jordan, Paul C., Sarah Stevens, Yuen Yi C. Tam, et al.. (2016). Activation Pathway of a Nucleoside Analog Inhibiting Respiratory Syncytial Virus Polymerase. ACS Chemical Biology. 12(1). 83–91. 14 indexed citations
7.
Zhang, Qingling, Justin G. Julander, Antitsa Stoycheva, et al.. (2015). Development of a Hyperglycosylated IFN Alfacon-1 (CIFN): Toward Bimonthly or Monthly Dosing for Antiviral Therapies. Journal of Interferon & Cytokine Research. 35(8). 621–633. 2 indexed citations
8.
Wang, Guangyi, Yanzhen He, Debasis Das, et al.. (2009). HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives. Bioorganic & Medicinal Chemistry Letters. 19(15). 4476–4479. 15 indexed citations
10.
Mackman, Richard L., Lijun Zhang, Constantine G. Boojamra, et al.. (2007). Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs. Bioorganic & Medicinal Chemistry. 15(16). 5519–5528. 24 indexed citations
11.
Mackman, Richard L., Lijun Zhang, Constantine G. Boojamra, et al.. (2007). Synthesis And Anti-Hiv Activity Of Cyclic Pyrimidine Phosphonomethoxy Nucleosides And Their Prodrugs: A Comparison Of Phosphonates And Corresponding Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 26(6-7). 573–577. 17 indexed citations
12.
Stoycheva, Antitsa, Charles L. Brooks, & José N. Onuchic. (2004). Gatekeepers in the Ribosomal Protein S6: Thermodynamics, Kinetics, and Folding Pathways Revealed by a Minimalist Protein Model. Journal of Molecular Biology. 340(3). 571–585. 24 indexed citations
13.
Stoycheva, Antitsa, José N. Onuchic, & Charles L. Brooks. (2003). Effect of gatekeepers on the early folding kinetics of a model β-barrel protein. The Journal of Chemical Physics. 119(11). 5722–5729. 21 indexed citations
14.
Stoycheva, Antitsa & Sherwin J. Singer. (2002). Computer simulations of a two-dimensional system with competing interactions. Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics. 65(3). 36706–36706. 30 indexed citations
15.
Stoycheva, Antitsa & Sherwin J. Singer. (2001). Scaling theory for two-dimensional systems with competing interactions. Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics. 64(1). 16118–16118. 15 indexed citations
16.
Stoycheva, Antitsa & Sherwin J. Singer. (2000). Stripe Melting in a Two-Dimensional System with Competing Interactions. Physical Review Letters. 84(20). 4657–4660. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026